Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ardent Health, Inc. securities between July 18, 2024, and November 12, 2025, of the March 9, 2026, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Ardent Health securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by March 9, 2026, to serve as lead plaintiff [2] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company [3] - The firm has been ranked No. 1 for securities class action settlements in 2017 and has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 [3] Group 3: Case Allegations - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable, claiming an active monitoring process that was not actually employed [4] - Defendants downplayed issues related to increased claim denials by third-party payors and did not write off uncollectible accounts, leading to inflated accounts receivable figures [4] - Ardent Health's professional liability reserves were insufficient to cover claims, contrary to their public statements about maintaining adequate insurance [4]

BENSALEM, Pa., Jan. 22, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Ardent Health, Inc. ("Ardent" or the "Company") (NYSE: ARDT). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ARDENT HEALTH, INC. (ARDT), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE MARCH 9, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Contact the Law Offices o ...

SAN FRANCISCO, Jan. 22, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman is notifying Ardent Health, Inc. (NYSE: ARDT) investors that a securities class action lawsuit has been filed against the company and certain of its executives following the company’s disastrous Q3 2025 financial results. Hagens Berman is investigating the alleged claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves. The firm urges inves ...

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Ardent Health, Inc. related to misrepresentation and failure to disclose critical financial information [1][2]. Group 1: Allegations of Misrepresentation - Insiders at Ardent Health allegedly misrepresented the company's reliance on "detailed reviews of historical collections" for determining the collectability of accounts receivable [2]. - The accounts receivable framework reportedly utilized a "180-day cliff," allowing Ardent Health to report inflated accounts receivable and postpone recognizing losses on uncollectible accounts [2]. - It was disclosed that Ardent Health did not maintain sufficient professional malpractice liability insurance to cover claims arising from its operations [2]. Group 2: Shareholder Involvement - Shareholders who purchased ARDT prior to July 18, 2024, are encouraged to contact Kuehn Law to enforce their rights, as there may be limited time to act [2]. - The firm emphasizes the importance of shareholder participation in maintaining the integrity and fairness of financial markets [3].

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ardent Health, Inc. (NYSE: ARDT). Shareholders who purchased shares of ARDT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/ardent-health-inc-loss-submission-form/?id=183202&from=4 CLASS PERIOD: July 18, 202 ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit was filed by Bleichmar Fonti & Auld LLP on behalf of investors in Ardent Health securities, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case, which is pending in the U.S. District Court for the Middle District of Tennessee [3]. Group 2: Allegations Against Ardent Health - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming it relied on "detailed reviews of historical collections," while in reality, it utilized a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardent To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardent between July 18, 2024 and November 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - January 21, 2026) ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for allegedly misleading investors regarding its accounts receivable practices during the Class Period from July 18, 2024, to November 12, 2025 [4]. Group 1: Lawsuit Details - The lawsuit claims that Ardent misrepresented its method of determining the collectability of accounts receivable, stating it used detailed historical reviews, while in reality, it relied on a 180-day cliff for reserving accounts [4]. - On November 12, 2025, Ardent disclosed a $43 million reduction in revenue and a $54 million increase in professional liability reserves, leading to a significant drop in share price by approximately 33.8% [5]. Group 2: Investor Actions - Investors have until March 9, 2026, to apply to be appointed as lead plaintiff in the class action, which allows them to oversee litigation and influence key decisions [2]. - The law firm Kirby McInerney LLP is handling the case and encourages affected investors to contact them for more information [7].

Core Viewpoint - The Ardent Health class action lawsuit alleges that the company and its executives made misleading statements regarding financial practices and failed to disclose critical information about accounts receivable and liability reserves, leading to significant financial losses for investors during the specified class period [1][3][4]. Company Overview - Ardent Health, Inc. operates a network of hospitals and clinics providing various healthcare services [2]. Allegations of the Lawsuit - The lawsuit claims that Ardent Health did not rely on accurate methods for determining the collectability of accounts receivable, which allowed the company to report inflated figures [3]. - It is alleged that Ardent Health's accounts receivable framework utilized a 180-day cliff for reserving accounts, delaying the recognition of losses on uncollectible accounts [3]. - The lawsuit states that Ardent Health did not maintain sufficient professional malpractice liability insurance and that its reserves were inadequate to cover increasing social inflationary pressures in medical malpractice cases [3]. Financial Impact - On November 12, 2025, Ardent Health reported a $43 million decrease in third-quarter 2025 revenue due to revised accounts receivable collectability assessments after transitioning to a new revenue accounting system [4]. - The company also cut its 2025 EBITDA guidance by approximately 9.6%, from a range of $575 million - $615 million to $530 million - $555 million, citing persistent industry-wide cost pressures [4]. - Following these announcements, Ardent Health's stock price fell nearly 34% [4]. Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows investors who purchased Ardent Health securities during the class period to seek appointment as lead plaintiff in the lawsuit, representing the interests of all class members [5].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Ardent Health, Inc. regarding a class action lawsuit due to alleged false statements and misleading financial practices related to accounts receivable and professional liability reserves [1][3]. Group 1: Allegations - The complaint alleges that Ardent Health did not rely on "detailed reviews of historical collections" for determining the collectability of accounts receivable, instead using a 180-day cliff for reserving accounts, which inflated reported receivables [3]. - It is claimed that Ardent Health's professional liability reserves were insufficient to cover claims due to "significant social inflationary pressure" in medical malpractice cases, particularly in the New Mexico market [3]. Group 2: Class Action Details - The class period for the lawsuit is from July 18, 2024, to November 12, 2025, and shareholders are encouraged to register for participation by March 9, 2026 [4]. - Shareholders who register will receive updates through a portfolio monitoring software regarding the case's progress [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud, aiming to ensure responsible business practices [5].